CIK 0001513525 · Non-accelerated filer<br>Smaller reporting company
Azora Therapeutics, Inc. (DE)
Sign in to watch- Ticker
- AZR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800667150
- Phone
- 434-422-9800
- Business address
- 16501 VENTURA BLVD, SUITE 400, ENCINO, CA, 91436
- Former names
- ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.
- 4 Grant or award Chief Executive Officer acquired 201,109 shares (grant or award)
- 4 Grant or award Director acquired 3,731 shares (grant or award)
- 8-K Event Material agreement
- 8-K Event Other events
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Other events
- 8-K Event Executive or director change
- S-1 Offering Registration Statement
- D Other Notice of Sales of Unregistered Securities
- 4/A Derivatives Options or other derivatives
- 4/A Open-market buy Director bought 90,000 shares
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · Unregistered share sale
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure · Other events
Page 20 of 30 · 581 filings